Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis

被引:27
|
作者
Cao, YH [1 ]
Hamada, T [1 ]
Matsui, T [1 ]
Date, T [1 ]
Iwabuchi, K [1 ]
机构
[1] Kanazawa Med Univ, Dept Biochem, Uchinada, Ishikawa 9200293, Japan
关键词
HCV; core; p53; 53BP2; apoptosis; yeast two-hybrid system;
D O I
10.1016/j.bbrc.2004.01.124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The core protein of Hepatitis C virus affects several biological functions of the host cells such as cellular growth and apoptosis. The core was shown to interact with 53BP2/Bbp/ASPP2, a p53-binding protein, in a yeast two-hybrid assay. The core competed with p53 in binding to ASPP2 in vitro. In an apoptosis assay using human osteosarcoma. Saos-2 cells or hepatocellular carcinoma HepG2 cells, ectopic expression of p53 induced apoptosis and ASPP2 enhanced this p53-induced apoptosis. However, coexpression of the core with p53 and ASPP2 increased the number of surviving cells. In a reporter assay, neither ASPP2 nor the core with ASPP2 affected the transcriptional activity of p53 on the promoters of Bax and p21, major p53 target genes. These findings suggest that the core inhibits p53-mediated apoptosis by blocking the interaction between p53 and ASPP2, without modulating the transcriptional activity of p53, which plays a role in oncogenesis of hepatocellular carcinoma. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:788 / 795
页数:8
相关论文
共 50 条
  • [1] HCVNS5A interacts with p53 and inhibits p53-mediated apoptosis
    Lan, KH
    Sheu, ML
    Hwang, SJ
    Yen, SH
    Chen, SY
    Wu, JC
    Wang, YJ
    Kato, N
    Omata, M
    Chang, FY
    Lee, SD
    ONCOGENE, 2002, 21 (31) : 4801 - 4811
  • [2] A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis
    Nelson, V
    Davis, GE
    Maxwell, SA
    APOPTOSIS, 2001, 6 (03) : 221 - 234
  • [3] p53 Target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation
    Sun, Wei-Tzu
    Hsieh, Pei-Chen
    Chiang, Ming-Lun
    Wang, Mei-Chih
    Wang, Fung-Fang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (02) : 395 - 398
  • [4] A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis
    V. Nelson
    G. E. Davis
    S. A. Maxwell
    Apoptosis, 2001, 6 : 221 - 234
  • [5] HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis
    Keng-Hsin Lan
    Meei-Ling Sheu
    Shinn-Jang Hwang
    Sang-Hue Yen
    Shiow-Yi Chen
    Jaw-Ching Wu
    Yuan-Jan Wang
    Naoya Kato
    Masao Omata
    Full-Young Chang
    Shou-Dong Lee
    Oncogene, 2002, 21 : 4801 - 4811
  • [6] Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
    Chen, D
    Padiernos, E
    Ding, F
    Lossos, IS
    Lopez, CD
    CELL DEATH AND DIFFERENTIATION, 2005, 12 (04) : 358 - 368
  • [7] Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
    D Chen
    E Padiernos
    F Ding
    I S Lossos
    C D Lopez
    Cell Death & Differentiation, 2005, 12 : 358 - 368
  • [8] p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis
    Yi Ao
    Larry H Rohde
    Louie Naumovski
    Oncogene, 2001, 20 : 2720 - 2725
  • [9] p53-interacting protein 53BP2 inhibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis
    Ao, Y
    Rohde, LH
    Naumovski, L
    ONCOGENE, 2001, 20 (21) : 2720 - 2725
  • [10] Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer
    Patel, Kinjal D.
    Barasiya, Yesha, V
    Patel, Jayendra B.
    Patel, Prabhudas S.
    ARCHIVES OF ORAL BIOLOGY, 2020, 119